Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)

Jacques Éric Gottenberg ,Zahir Amoura ,Emmanuel Chatelus ,Yves Allenbach ,Anne‐Sophie Korganow ,J.f Kleinmann ,Antoine Poulet ,Divi Cornec ,Emeline Gaigneux ,A Mékinian ,R Jaussaud ,Benjamin Terrier ,Azeddine Dellal ,Raphaèle Séror ,H Nielly ,G Baulier ,P Cacoub ,Marie Desmurs ,Marie-Élise Truchetet ,Sébastien Ottaviani ,Jean Sibilia ,Boris Bienvenu ,André Vincent ,Aurélien Guffroy ,J Henry ,Valérie Devauchelle‐Pensec ,A Saunier ,Samira Litim-Ahmed-Yahia ,M Gatfossé ,Mathieu Ete ,Laurence Bouillet ,C Larroche ,Aurore Chaudier ,Christelle Sordet ,Isabelle Melki ,Bénedicte Rouvière ,Martin Michaud ,É Hachulla ,Guillaume Vial ,Mathieu Jouvray ,Pierre-Yves Jeandel ,Amélie Leurs ,Christophe Richez ,Renaud Felten ,Alain Meyer ,Pierre Quartier ,Xavier Mariette

doi:10.1136/rmdopen-2022-002324

Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)

Jacques Éric Gottenberg , Zahir Amoura + Show 45 more

Open Access

https://doi.org/10.1136/rmdopen-2022-002324

Copy DOI

Journal: RMD Open	Publication Date: Nov 1, 2022
Citations: 4	License type: open-access

#Refractory Autoimmune Diseases #Autoimmune Diseases + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

ObjectivesTo assess the tolerance and efficacy of targeted therapies prescribed off-label in refractory low-prevalence autoimmune and inflammatory systemic diseases.MethodsThe TATA registry (TArgeted Therapy in Autoimmune Diseases) is a prospective, observational,...

Full Text